Survival Analysis of Patients with metastatic Gastric Cancer Using Cox Regression Model

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 408

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CANCERMED04_070

تاریخ نمایه سازی: 17 مرداد 1398

Abstract:

Introduction and Aim: Gastric cancer (GC) is one the most common causes of death all over the world and The fifth most common cancer in Iran. The survival rate after diagnosis is low. The aimed is to assess the survival of patients with metastatic GC and affected factors. Methods: In this study, 109 patients aged from 22 to 85 years old with metastatic GC, referred to trained hospitals in Kerman from 2001 to 2015 are studied and the effect of variables such as age at the time of diagnosis, gender, smoking, addiction, place of living (rural and urban district), surgical, chemotherapy, radiotherapy, histological grade, Morphology, family history were evaluated. We used Cox regression for identifying significant variables. Data were analyzed using version 3.5.1 of R.Results: 74 patients (67.9%) died at the end of follow-up. The mean and median survival time of patients was 24.8±2.8 and 16 months, respectively. Survival probability of one, three and five year of istological gradeh ,In the univariate analysispatients were 0.56, 0.28 and 0.19, respectively. (HR=1.45, p=0.14), opium (HR=1.6, p=.04) and place of living (HR=0.67, p=0.16) were significant prognostic factors, the multivariate analysis showed that opium associated with survival in patients with metastatic gastric cancers (HR=1.72, P=0.03). Conclusions: The survival time for with metastatic GC was found to be short. This time decreased with opium consumption in patients. with early diagnosis GC by screening, the survival time patients with metastatic GC can be increased.

Authors

Touba narimani moghadam

MSc Student of Biostatistics, Department of Epidemiology and Biostatistics, School of Public of Medical Sciences, Kerman, Iran

Moghaddameh Mirzaee

Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Yunes Jahani

Assistant professor, Department of Epidemiology and Biostatistics School of Public Health, Kerman University of Medical Sciences, Kerman, Iran

Abbas Bahrampour

Professor of Biostatistics, Department of Biostatistics and Epidemiology Kerman University of Medical Sciences, Research Center for Modeling in Health, institute for Futures Studies in health Kerman, Iran